NIK inhibitors (Genentech)

N/A

Report date: 2025/01/26 15:58:42
NME

Base Information

Drug NameNIK inhibitors (Genentech)
Drug Alias NameNIK-SMI1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-Activated Protein Kinase Kinase Kinase 14 inhibitors
TargetsMitogen-Activated Protein Kinase Kinase Kinase 14
Therapy Area/IndicationsLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesGenentech Inc
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A